New drug aims to keep moms Opioid-Free after C-Section
NCT ID NCT07534709
First seen Apr 23, 2026 · Last updated Apr 29, 2026 · Updated 2 times
Summary
This study tests if adding suzetrigine to standard pain relief helps more women stay opioid-free for 3 days after a C-section. About 90 women will get either suzetrigine or a placebo, plus usual medicines like acetaminophen. Opioids will still be available if needed. The goal is to reduce opioid use and improve recovery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CESAREAN SECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Texas at Austin Dell Medical School, Department of Women's Health
Austin, Texas, 78705, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Conditions
Explore the condition pages connected to this study.